These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34753233)

  • 1. [Systemic light chain amyloidosis with amyloid myopathy as the main manifestation: a case report].
    Zhang W; Jiang LJ; Ma YP; Bao S; Chen JM; Li R; Ye XP; Wei YP; Zhi F; Tian J; Li YQ; Song LJ
    Zhonghua Xue Ye Xue Za Zhi; 2021 Sep; 42(9):768. PubMed ID: 34753233
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic light chain amyloidosis myopathy responsive to daratumumab monotherapy.
    Chitimus DM; Berling E; Garderet L; Venturelli N; Malfatti E; Authier FJ; Nicolas G; Laforêt P; Lefeuvre C
    Eur J Neurol; 2023 Mar; 30(3):745-748. PubMed ID: 36403110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teaching neuroimages: dyspnea as a presenting manifestation of amyloid myopathy.
    Ghosh PS; Thaera GM; Tracy JA
    Neurology; 2013 Dec; 81(24):e184. PubMed ID: 24323446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myopathy in a patient with systemic AA amyloidosis possibly induced by psoriasis vulgaris: An autopsy case.
    Tanabe H; Maki Y; Urabe S; Higuchi I; Obayashi K; Hokezu Y
    Muscle Nerve; 2015 Dec; 52(6):1113-7. PubMed ID: 26179325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myopathy as the initial manifestation of primary amyloidosis.
    Keith J; Afshar-Ghotli Z; Roussev R; Ernst B; Young B; Bilbao JM
    Can J Neurol Sci; 2011 Jan; 38(1):161-4. PubMed ID: 21156452
    [No Abstract]   [Full Text] [Related]  

  • 6. Isaacs' syndrome with overlapping myopathy as the first manifestation of AL amyloidosis.
    Nardetto L; Briani C; Fedrigo M; Castellani C; Valente M; Polverino De Laureto P; Santelli L; Angelini A; Giometto B
    J Neurol; 2016 Nov; 263(11):2332-2335. PubMed ID: 27699467
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuromuscular amyloidosis: Unmasking the master of disguise.
    Pinto MV; Dyck PJB; Liewluck T
    Muscle Nerve; 2021 Jul; 64(1):23-36. PubMed ID: 33458861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic amyloidosis in a patient presenting with myopathy, peripheral oedema and proteinuria.
    Bywater L; Gist AC; Muthalaly RG; Loh J; Simpson I; White AJ; Lim AK
    Med J Aust; 2022 Sep; 217(5):232-234. PubMed ID: 35924379
    [No Abstract]   [Full Text] [Related]  

  • 9. Isolated myopathy as the initial manifestation of primary systemic amyloidosis.
    Karacostas D; Soumpourou M; Mavromatis I; Karkavelas G; Poulios I; Milonas I
    J Neurol; 2005 Jul; 252(7):853-4. PubMed ID: 15742103
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of isolated amyloid myopathy.
    Liewluck T; Milone M
    Eur J Neurol; 2017 Dec; 24(12):1437-1445. PubMed ID: 28888072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic Immunoglobulin Light Chain Amyloidosis-Associated Myopathy: Presentation, Diagnostic Pitfalls, and Outcome.
    Muchtar E; Derudas D; Mauermann M; Liewluck T; Dispenzieri A; Kumar SK; Dingli D; Lacy MQ; Buadi FK; Hayman SR; Kapoor P; Leung N; Chakraborty R; Gonsalves W; Russell S; Lust JA; Lin Y; Go RS; Zeldenrust S; Kyle RA; Rajkumar SV; Gertz MA
    Mayo Clin Proc; 2016 Oct; 91(10):1354-1361. PubMed ID: 27712634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axial myopathy due to primary amyloidosis.
    Friedman Y; Paul JT; Turley J; Hazrati LN; Munoz D
    Muscle Nerve; 2007 Oct; 36(4):542-6. PubMed ID: 17405139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myopathy and mixed hyperlipoproteinemia as the first symptom of systemic AL-amyloidosis].
    Tosovský M; Soukup T; Bradna P; Maisnar V; Tycová V; Toms J; Prixová M
    Vnitr Lek; 2008 Oct; 54(10):1014-9. PubMed ID: 19009771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of isolated primary amyloidosis in the medial rectus muscle.
    Jeon CY; Jin SY; Jang JW; Kim US
    Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):395-6. PubMed ID: 22119881
    [No Abstract]   [Full Text] [Related]  

  • 15. AL amyloidosis with non-amyloid forming monoclonal immunoglobulin deposition; a case mimicking AHL amyloidosis.
    Manabe S; Iwasaki C; Hatano M; Kametani F; Yazaki M; Nitta K; Nagata M
    BMC Nephrol; 2018 Nov; 19(1):337. PubMed ID: 30466387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of amyloid myopathy diagnosed during the treatment of myopathy associated with anti-signal recognition particle antibodies].
    Kawakami N; Katsuyama Y; Hagiwara Y; Yoshida H; Kim K; Harada K
    Rinsho Shinkeigaku; 2017 Apr; 57(4):168-173. PubMed ID: 28367947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid myopathy presenting with distal atrophic weakness.
    Smestad C; Monstad P; Lindboe CF; Mygland A
    Muscle Nerve; 2004 Apr; 29(4):605-9. PubMed ID: 15052628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral purpura as the first manifestation of primary systemic amyloidosis.
    McCormick RS; Sloan P; Farr D; Carrozzo M
    Br J Oral Maxillofac Surg; 2016 Jul; 54(6):697-9. PubMed ID: 26708800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissecting the Molecular Features of Systemic Light Chain (AL) Amyloidosis: Contributions from Proteomics.
    Rognoni P; Mazzini G; Caminito S; Palladini G; Lavatelli F
    Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic amyloidosis manifestation in a patient with psoriatic arthritis.
    Souza BCE; Gavioli CFB; Oliveira WRP; Romiti R
    An Bras Dermatol; 2021; 96(3):324-327. PubMed ID: 33781647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.